LEPR and colorectal carcinoma: When we repeated the analyses in patients with CRC diagnosed at a later stage (i.e., stage III/IV), we observed similar results for DFS (LEP rs11763517, HR, 0.63; 95% CI, 0.44–0.91; LEPR rs7602, HR, 0.39; 95% CI, 0.24–0.63; and LEPR rs9436301, HR, 0.55; 95% CI, 0.37–0.82).